These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Physician-controlled source selection--a suggested approach to substitution. Chadwick BM J Leg Med (N Y); 1976 Mar; 4(3):27-32. PubMed ID: 1083406 [No Abstract] [Full Text] [Related]
3. American Academy of Pediatrics Committee on Drugs: Generic prescribing, generic substitution, and therapeutic substitution. Pediatrics; 1987 May; 79(5):835. PubMed ID: 3575043 [No Abstract] [Full Text] [Related]
4. Benefits and liabilities of generic prescribing. Lee AM W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384 [No Abstract] [Full Text] [Related]
5. Prescriptions enter the political arena. Regier H J Leg Med (N Y); 1974; 2(2):24-30. PubMed ID: 4545342 [No Abstract] [Full Text] [Related]
6. The importance of bioavailability to the pharmacist. Canada AT Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):346-8. PubMed ID: 1158541 [TBL] [Abstract][Full Text] [Related]
7. Letter: Antisubstitution vs. cooperative substitution. Jones ME; Helling DK; Widmer RB Am Fam Physician; 1976 Jul; 14(1):27. PubMed ID: 937160 [No Abstract] [Full Text] [Related]
8. [Biopharmaceutics, biodisposibility, bioequivalency]. Cingolani E Ann Ist Super Sanita; 1982; 18(3):531-2. PubMed ID: 7187840 [No Abstract] [Full Text] [Related]
9. Genesis of generic drugs. Calesnick B; Kreider LA; Dinan A Pa Med; 1986 Dec; 89(12):32, 34, 36. PubMed ID: 3808720 [No Abstract] [Full Text] [Related]
10. Trade names or approved names. Part IV. The solution. Prescribing and the regulation of formulation. Beckett AH Postgrad Med J; 1974 Feb; 50(580):125-9. PubMed ID: 4465774 [TBL] [Abstract][Full Text] [Related]
11. Brand versus generic prescribing: a perspective of the Indian cardiologists' viewpoint. Bansinath M; Sequeira RP; Shukla VK; Mathur VS Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):279-83. PubMed ID: 6746151 [TBL] [Abstract][Full Text] [Related]